Skip to main content

Advertisement

Table 3 Clinical characteristics of the study samples (N; percentages in parentheses)

From: Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P)

  German reference men [n = 988] German PC patients with scheduled radiotherapy [n = 121] German PC patients with scheduled radical prostatectomy [n = 371] p-values for differences between German RT and RP patients Canadian PC patients with scheduled radiotherapy [n = 66] Canadian PC patients with scheduled radical prostatectomy [n = 68] p-values for differences between Canadian RT and RP patients
D'Amico Risk Score Not    p < 0.001#    
Low   39 (32.2) 24 (6.5)     
Intermediate   39 (32.2) 46 (12.4)     
High applicable 43 (35.5) 301 (81.1)   - -  
Gleason score (pre-treatment) Mean ± SD Not applicable 6.13 ± 1.33 6.35 ± 1.21 p < 0.096* - -  
Highest recorded pre-treatment PSA [ng/ml] (mean ± SD) Not applicable 13.7 ± 17.3 10.2 ± 17.9 p = 0.066* 14.3 ± 14.6 8.81 ± 6.9 p = 0.006*
  1. Gleason score and D'Amico risk score were not assessed in the Canadian study
  2. * analysis of variance # chi-square tests